Legend Biotech Corporation (LEGN) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -85.35M | -105.64M | 28.8M | -13.04M | -103.75M | -82.08M | -75.82M | -1.65M | 15.52M | -95.64M | -60.85M | -97.57M | -139.22M | -49.74M | -72.11M | -740K | -78.69M | -69.55M | -44.59M | -57.54M |
| Operating CF Margin % | -27.98% | -34.48% | 10.58% | -5.11% | -53.19% | -44% | -47.33% | -0.89% | 16.51% | -120.36% | -63.37% | -133.05% | -383.13% | -180.01% | -263.56% | -6.18% | -190.38% | -178.35% | -261.74% | -276.17% |
| Operating CF Growth % | 17.73% | -28.71% | 137.99% | -689.95% | -768.6% | 14.18% | -24.61% | 98.31% | 111.15% | -92.28% | 15.62% | -13084.86% | -76.92% | 28.48% | -61.71% | 98.71% | -193.75% | -24.3% | 30.73% | -1.15% |
| Net Income | -54.46M | -30.95M | -39.07M | -124.8M | -99.13M | 40.51M | -120.89M | -17.97M | -59.79M | -146.81M | -62.49M | -198.84M | -111.97M | -135.72M | -84.8M | -184.11M | -41.09M | -88.33M | -125.39M | -91.58M |
| Depreciation & Amortization | 15.65M | 12.02M | 5.88M | 5.85M | 5.2M | 6.8M | 3.91M | 5.37M | 5.72M | 5.35M | 5.17M | 4.75M | 5.18M | 5.25M | 5.11M | 4.11M | 3.93M | 3.71M | 3.5M | 6.71M |
| Stock-Based Compensation | 0 | 0 | 15.02M | 18.7M | 15.95M | 13.39M | 15.11M | 21.74M | 18.7M | 12.59M | 12.38M | 15.64M | 7.07M | 8.97M | 10.24M | 9.45M | 5.67M | 5.2M | 6.92M | 8.03M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 77.86M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 28.99M | -55.46M | -30.07M | 123.79M | 47.82M | -62.7M | 24.05M | -13.78M | -43.16M | 44.82M | -14.11M | 99.59M | -7.65M | 12.49M | -57.62M | 5.22M | -20.67M | -28.12M | 37.83M | -66.57M |
| Working Capital Changes | -75.52M | -31.25M | 77.05M | -36.59M | -73.59M | -80.08M | 1.99M | 2.99M | 94.05M | -11.59M | -1.79M | -18.43M | -31.84M | 59.27M | 54.96M | 86.73M | -26.53M | 37.99M | 32.55M | 85.88M |
| Change in Receivables | 11.43M | -138.37M | 25.79M | -26.2M | 5.92M | -5.58M | 12.36M | -9.76M | 96.73M | -99.05M | 15.04M | -15.01M | 34K | -31K | 403K | 49.99M | -39K | -48.91M | 13.5M | 60M |
| Change in Inventory | 702.09K | -3.86M | 5.37M | -2.79M | -3.23M | -6.26M | -5.08M | -1.39M | -4.47M | -5.05M | -2.82M | -3.25M | -2.17M | 75K | -2.27M | -5.26M | -1.15M | -115K | 72K | 94K |
| Change in Payables | -8.12M | -15.9M | 24.27M | 16.52M | 19.51M | 7.5M | -12.82M | -1.95M | 22.8M | 3.02M | -4.37M | 0 | -3.08M | -4.65M | 25.33M | 2.5M | 0 | -4.55M | 592K | 0 |
| Cash from Investing | -168.5M | 640.22M | -20M | -165.53M | 256.64M | -87.84M | 329.08M | -695.63M | -396.15M | 407.51M | -209.07M | -121.68M | 16.03M | 24.93M | 127.89M | 2.58M | -232.5M | 96.51M | -105.67M | -168.67M |
| Capital Expenditures | -25.98M | -20.92M | -5M | -9.22M | -2M | -2.38M | -2.06M | -3.42M | -6.25M | -4.34M | -5.38M | -6.09M | -4.27M | -6.55M | -2.58M | -559K | -12.12M | -3.5M | -11.48M | -28.93M |
| CapEx % of Revenue | 8.51% | 6.83% | 1.84% | 3.62% | 1.03% | 1.27% | 1.29% | 1.83% | 6.64% | 5.47% | 5.6% | 8.3% | 11.76% | 23.71% | 9.42% | 4.67% | 29.32% | 8.97% | 67.39% | 138.84% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 881K | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | -8.68M | -6.3M | -15.36M | -5.23M | -15.41M | -17.15M | -16.54M | -21.09M | -26.37M | -115.59M | -26.3M | -7.43M | -172K | -8.04M | -220.38M | 326K | -1.13M | -139.75M |
| Cash from Financing | -1.2M | -648.48K | 670K | -990K | 667K | -333K | 4.25M | 955K | 831K | 925K | 961K | 789.89M | -444K | -783K | 377.73M | 1.01M | 25K | 323.56M | 1.14M | 301.75M |
| Debt Issued (Net) | 0 | 0 | -602K | -1.26M | -777K | -936K | -1.16M | -1.16M | -758K | 304K | -1.72M | -1.52M | -814K | -1.41M | -703K | -52K | -434K | -422K | -447K | -379K |
| Equity Issued (Net) | 100.3K | 313.82K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 377.64M | 0 | 0 | 323.44M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -1.3M | -962.3K | 1.27M | 273K | 1.44M | 603K | 5.41M | 2.12M | 1.59M | 621K | 2.68M | 789.89M | 370K | 624K | 785K | 1.06M | 459K | 543K | 1.59M | 302.13M |
| Net Change in Cash | -255.48M | 622.94M | 12.31M | -175.12M | 154.95M | -172.53M | 258.02M | -696.32M | -380.14M | 314.24M | -269.74M | 573.16M | -125.98M | -26.7M | 432.96M | 1.99M | -311.15M | 350.6M | -149.88M | 75.92M |
| Free Cash Flow | -111.33M | -126.56M | 23.8M | -22.27M | -105.76M | -84.46M | -77.89M | -5.07M | 9.27M | -102.49M | -66.32M | -103.66M | -143.49M | -57.26M | -73.78M | -1.3M | -90.81M | -72.7M | -57.2M | -86.46M |
| FCF Margin % | -36.49% | -41.31% | 8.74% | -8.73% | -54.22% | -45.28% | -48.62% | -2.72% | 9.87% | -128.98% | -69.08% | -141.36% | -394.89% | -207.23% | -269.64% | -10.85% | -219.7% | -186.43% | -335.77% | -415.01% |
| FCF Growth % | -5.27% | -49.85% | 130.55% | -339.34% | -1240.47% | 17.6% | -17.44% | 95.11% | 106.46% | -78.99% | 10.11% | -7879.68% | -58.02% | 21.23% | -28.97% | 98.5% | -115.21% | -6.31% | 19.96% | -27.67% |
| FCF per Share | -0.60 | -0.69 | 0.13 | -0.12 | -0.58 | -0.46 | -0.43 | -0.03 | 0.05 | -0.56 | -0.36 | -0.59 | -0.87 | -0.36 | -0.47 | -0.01 | -0.59 | -0.50 | -0.39 | -0.62 |
| FCF Conversion (FCF/Net Income) | 1.57x | 3.43x | -0.73x | 0.10x | 1.03x | -3.12x | 0.61x | 0.09x | -0.26x | 0.66x | 0.98x | 0.49x | 1.24x | 0.37x | 0.85x | 0.00x | 1.92x | 0.79x | 0.36x | 0.63x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31K | 0 | 0 | 73K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |